Skip to main content
. 2019 Oct 11;116(41):692–702. doi: 10.3238/arztebl.2019.0692

Figure 3.

Figure 3

Forest plot of the meta-analysis of randomized and quasi-randomized clinical trials on the question of corticosteroids vs. placebo (modified from [30]; with the kind permission of Wiley). The clinical endpoint is incomplete resolution of weakness 6 months or more after randomization. CI, confidence interval; RR, relative risk; heterogeneity 18%; a fixed-effects model was used in the analysis.